JP2002543192A5 - - Google Patents

Download PDF

Info

Publication number
JP2002543192A5
JP2002543192A5 JP2000615600A JP2000615600A JP2002543192A5 JP 2002543192 A5 JP2002543192 A5 JP 2002543192A5 JP 2000615600 A JP2000615600 A JP 2000615600A JP 2000615600 A JP2000615600 A JP 2000615600A JP 2002543192 A5 JP2002543192 A5 JP 2002543192A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
dihydro
group
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000615600A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002543192A (ja
JP4958338B2 (ja
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed filed Critical
Publication of JP2002543192A publication Critical patent/JP2002543192A/ja
Publication of JP2002543192A5 publication Critical patent/JP2002543192A5/ja
Application granted granted Critical
Publication of JP4958338B2 publication Critical patent/JP4958338B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000615600A 1999-05-04 2000-05-01 プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体 Expired - Fee Related JP4958338B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US60/183,013 1999-05-04
US09/552,354 2000-04-19
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011749 WO2000066570A1 (en) 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011249051A Division JP5523430B2 (ja) 1999-05-04 2011-11-14 プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体

Publications (3)

Publication Number Publication Date
JP2002543192A JP2002543192A (ja) 2002-12-17
JP2002543192A5 true JP2002543192A5 (cg-RX-API-DMAC10.html) 2007-06-21
JP4958338B2 JP4958338B2 (ja) 2012-06-20

Family

ID=26878649

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000615600A Expired - Fee Related JP4958338B2 (ja) 1999-05-04 2000-05-01 プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体
JP2011249051A Expired - Fee Related JP5523430B2 (ja) 1999-05-04 2011-11-14 プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011249051A Expired - Fee Related JP5523430B2 (ja) 1999-05-04 2011-11-14 プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体

Country Status (24)

Country Link
EP (1) EP1175411B1 (cg-RX-API-DMAC10.html)
JP (2) JP4958338B2 (cg-RX-API-DMAC10.html)
KR (1) KR100732692B1 (cg-RX-API-DMAC10.html)
CN (1) CN1131856C (cg-RX-API-DMAC10.html)
AT (1) ATE386729T1 (cg-RX-API-DMAC10.html)
AU (1) AU766801B2 (cg-RX-API-DMAC10.html)
BG (1) BG65277B1 (cg-RX-API-DMAC10.html)
BR (1) BR0010214A (cg-RX-API-DMAC10.html)
CA (1) CA2371712C (cg-RX-API-DMAC10.html)
CZ (1) CZ20013952A3 (cg-RX-API-DMAC10.html)
DE (1) DE60038108T2 (cg-RX-API-DMAC10.html)
DK (1) DK1175411T3 (cg-RX-API-DMAC10.html)
EA (1) EA004511B1 (cg-RX-API-DMAC10.html)
ES (1) ES2301482T3 (cg-RX-API-DMAC10.html)
GE (1) GEP20043181B (cg-RX-API-DMAC10.html)
HU (1) HUP0203332A3 (cg-RX-API-DMAC10.html)
IL (1) IL146298A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA01011287A (cg-RX-API-DMAC10.html)
NO (1) NO321370B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ515353A (cg-RX-API-DMAC10.html)
PL (1) PL351083A1 (cg-RX-API-DMAC10.html)
SG (1) SG120970A1 (cg-RX-API-DMAC10.html)
SK (1) SK15922001A3 (cg-RX-API-DMAC10.html)
TR (1) TR200103285T2 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
JP4950027B2 (ja) * 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
BRPI0510260A (pt) * 2004-04-27 2007-10-23 Wyeth Corp método para purificar um composto, e, kit farmacêutico
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
AR049707A1 (es) * 2004-07-07 2006-08-30 Wyeth Corp Regimenes y kits de progestina ciclica
AU2005272854B2 (en) * 2004-08-13 2012-04-26 Wyeth Tanaproget derivatives, metabolites, and uses thereof
BRPI0610438A2 (pt) 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição
US7767668B2 (en) * 2005-04-28 2010-08-03 Wyeth Llc Micronized tanaproget, compositions, and methods of preparing the same
ES2431324T3 (es) * 2005-04-28 2013-11-26 Wyeth Llc Forma purificada de tanaproget
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007013469A (es) * 2005-04-28 2008-01-22 Wyeth Corp Forma ii polimorfa de tanaproget.
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5688808A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
AU717251B2 (en) * 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DE69724630T2 (de) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Similar Documents

Publication Publication Date Title
Clark et al. Lateral lithiation reactions promoted by heteroatomic substituents
AU2023270195A1 (en) 2,3-dihydroquinazolin compounds as NAV1.8 inhibitors
CA2789279C (en) 1,2,4-triazine-4-amine derivatives
AU2002210474B2 (en) Quinoline and quinazoline derivatives as ligands for the neuropetide Y receptor
CN105121436B (zh) 新的吡啶衍生物
WO2000066570A1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
TW201036946A (en) N-acylanthranilic acid derivative or salt thereof
TW201210990A (en) Manufacturing method for compounds having HIV integrase inhibitory activities
KR102012222B1 (ko) 무기질코르티코이드 수용체 조절제로서의 벤족사지논 아미드
NZ523839A (en) 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
JP2020520950A (ja) デングウイルス複製阻害剤としての置換インドリン誘導体
JPS6044308B2 (ja) クロマン誘導体の製法
JP2008520665A5 (cg-RX-API-DMAC10.html)
JP2012087129A5 (cg-RX-API-DMAC10.html)
KR20150006876A (ko) 광학적으로 순수하고 임의로 치환된 2-(1-히드록시-알킬)-크로멘-4-온 유도체의 제조방법 및 약제 제조에 있어서의 그의 용도
KR20030051747A (ko) 벤족사지논 유도체, 그의 제조 및 용도
CN108137511A (zh) 制备(e)-3-(4-((e)-2-(2-氯-4-氟苯基)-1-(1h-吲唑-5-基)丁-1-烯-1-基)苯基)丙烯酸的方法
CN105073724A (zh) 作为钾离子通道抑制剂的2,3-二氮杂萘类化合物
AU2005238520B2 (en) Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
EP1175411A1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
JPH06211761A (ja) アリールおよび複素環置換プロペンアミド誘導体
Wu et al. Preparation of isoquinazolines via metal-free [4+ 2] cycloaddition of ynamides with nitriles
AU2005247699A1 (en) Aminopyridine derivatives as selective dopamine D3 agonists
JP2002543193A5 (cg-RX-API-DMAC10.html)
JP2002543155A5 (cg-RX-API-DMAC10.html)